Cygnus Technologies
Cygnus Technologies specializes in providing analytical products and services to the pharmaceutical and biotechnology sectors, focusing on the development of therapeutic proteins, vaccines, antibodies, and gene therapies. The company offers a range of generic kits and immunoassay reagents specifically designed for bioprocess contaminant testing, with an emphasis on host cell protein detection in recombinant pharmaceuticals. Additionally, Cygnus Technologies delivers custom antibody and assay development services, which include antibody purification, conjugation, and the creation of tailored assays for quality control and process development. Their product offerings also encompass ELISA kits, DNA detection products, Western blot kits, and immunogenicity analysis products, enabling clients to enhance their research and development efforts effectively.
1 past transactions
MockV Solutions
Acquisition in 2020
MockV Solutions, Inc. is a biotechnology company based in Rockville, Maryland, specializing in the development of non-infectious mock virus particles (MVP) that replicate the characteristics of live infectious viruses. Founded in 2015, the company creates analytical kits designed for benchtop scientists, facilitating the straightforward and cost-effective quantification of viral clearance in industrial processes. By utilizing these mock virus particles as spiking agents during live virus analysis, MockV Solutions contributes to advancements in the biotechnology sector, ensuring enhanced safety and efficiency in various applications. As of March 2020, it operates as a subsidiary of Maravai Life Sciences Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.